Ras GTPase signaling |
DAB2 |
Disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) |
DOC2 |
5p13 |
Mitogen responsive phosphoprotein, suppresses the mitogenic signaling via Ras pathway, cell differentiation, cell proliferation |
Methylated |
[15] |
|
RASAL1 |
RAS protein activator like 1 (GAP1 like) |
RASAL |
12q23-q24 |
Ras GTPase-activating protein, negatively regulates Ras signaling |
Methylated |
[9] |
|
RASSF1 |
Ras association (RalGDS/AF-6) domain family 1 |
RASSF1A |
3p21.3 |
RAS effector protein, Ras signaling, cell cycle arrest, apoptosis, DNA repair, inhibits the accumulation of cyclin D1 |
Methylated, mutated |
[10]–[14]
|
|
SCGB3A1 |
Secretoglobin, family 3A, member 1 |
HIN1 |
5q35-qter |
AKT signaling pathway, cell communication |
Methylated |
[16] |
Rho GTPase signaling |
DLC1 |
Deleted in liver cancer 1 |
ARHGAP7, STARD12, p122-RhoGAP |
8p22.3 |
Cell cytoskeleton organization, GTPase activator, signal transduction, cell adhesion, invasion |
Methylated, deleted (LOH) |
[18] |
p53 signaling |
UCHL1 |
Ubiquitin carboxyl-terminal esterase L1 (Ubiquitin thiolesterase) |
PARK5, PGP9.5 |
4p14 |
Apoptosis, binds p53/MDM2 complex and activates p53 signaling |
Methylated |
[23] |
|
TP73 |
Tumor protein p73 |
p73 |
1p36.3 |
Cell cycle, DNA damage response, apoptosis, transcription factor |
Methylated |
[10] |
Wnt/β-catenin signaling |
WIF1 |
WNT inhibitory factor 1 |
WIF-1 |
12q14.3 |
Wnt-signaling pathway, binds and inhibits |
Methylated |
[26] |
WNT proteins, protein-tyrosine kinase activity |
Cell cycle signaling |
BRD7 |
Bromodomain containing 7 |
|
16q12 |
Transcriptional regulation, cell cycle regulation |
Methylated |
[31] |
|
CDKN2A |
Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
p16, INK4A, MTS1, CDK4I, CDKN2, p16INK4A |
9p21 |
Cell cycle regulation p16: inhibits CDK4 kinase |
p16: mutated, methylated, deleted |
[10],[12],[13],[30]
|
|
ARF |
Alternate open reading frame |
p14, p14ARF |
|
ARF: stabilizes p53, interacts with MDM2 |
ARF: methylated, deleted |
|
CDKN2B |
Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
p15, MTS2, TP15, INK4B |
9p21 |
Cyclin-dependent kinase inhibitor for CDK4 and CDK6, cell cycle regulation |
Methylated |
[10],[12],[13]
|
|
CHFR |
Checkpoint with forkhead and ring finger domains |
RNF116, RNF196 |
12q24.33 |
Mitotic checkpoint protein early in G2-M transition, cell cycle regulation |
Methylated |
[35] |
|
FHIT |
Fragile histidine triad gene |
FRA3B, AP3Aase |
3p14.2 |
Cell cycle regulation, G1-S phase checkpoint, DNA-damage response, nucleotide and nucleic acid metabolism |
Deleted, abnormal transcripts, methylated |
[37] |
|
MIP0L1 |
Mirror-image polydactyly 1 |
|
14q13.3 |
Cell cycle (G1-S phase) regulation, up-regulates p21 and p27 protein |
Methylated, deleted (LOH) |
[32] |
|
PTPRG |
Protein tyrosine phosphatase, receptor type, G |
PTPG, HPTPG, RPTPG |
3p21-p14 |
Cell proliferation, cell cycle regulation, signal transduction |
Methylated, deleted (LOH) |
[38] |
DNA damage signaling |
GADD45G |
Growth arrest and DNA-damage-inducible, gamma |
GADD45gamma, CR6, GRP17 |
9q22.1-q22.2 |
DNA-damage response |
Methylated, no mutation |
[34] |
|
MGMT |
0-6-methylguanine-DNA methyltransferase |
|
10q26 |
DNA repair, senses and integrates DNA damage/repair-related signals with replication, cell cycle and genomic stability |
Methylated |
[10],[14]
|
|
MLH1 |
Mut L homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
hMLM, HNPCC, FCC2 |
3p21.3 |
DNA mismatch repair protein, cell cycle G2/M arrest |
Methylated |
[10],[13]
|
Cell adhesion signaling |
CDH1 |
Cadherin 1, type 1, E-cadherin (epithelial) |
CDHE, ECAD, LCAM, CD324 |
16q22.1 |
Classical cadherin, calcium dependent cell-cell adhesion, proliferation, invasion, metastasis |
Methylated |
[10],[13],[39]
|
|
CADM1 |
Cell adhesion molecule 1 |
IGSF4, TSLC1, NECL2, RA175, synCAM1, SglGSF |
11q23.2 |
Ca2+/Mg2+-independent cell-cell adhesion, apoptosis |
Methylated |
[42] |
|
MMP19 |
Matrix metallopeptidase 19 |
MMP18, RASI-1 |
12q14 |
Matrix metalloproteinase, anti-angiogenesis |
Methylated, deleted (LOH) |
[45] |
|
OPCML |
Opioid binding protein/cell adhesion molecule-like |
OPCM, OBCAM |
11q25 |
IgLON immunoglobulin protein, cell adhension |
Methylated |
[46] |
|
PCDH10 |
Protocadherin 10 |
OL-PCDH,PCDH19 |
4q28.3 |
Protocadherin, cell-cell adhesion, apoptosis, cell signaling |
Methylated |
[43] |
|
TFPI2 |
Tissue factor pathway inhibitor 2 |
PP5 |
7q22 |
Serine protease inhibitor, metastasis |
Methylated |
[47] |
|
THBS1 |
Thrombospondin 1 |
TSP, THBS, TSP1 |
15q15 |
Adhesive glycoprotein, cell-to-cell and cell-to-matrix interactions, angiogenesis, cell signaling, cell motility |
Methylated |
[10] |
Apoptosis signaling |
CASP8 |
Caspase 8, apoptosis-related cysteine peptidase |
CAP4, MACH, MCH5, FLICE |
2q33-q34 |
Apoptosis |
Methylated |
[10] |
|
DAPK1 |
Death-associated protein kinase 1 |
DAPK |
9q34.1 |
Positive mediator of gamma-interferon induced apoptosis |
Methylated |
[12]–[14]
|
|
GSTP1 |
Glutathione S-transferase pi 1 |
DFN7, GST3 |
11q13 |
Apoptosis, metabolism, energy pathways |
Infrequently methylated |
[14] |